MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Generalized Anxiety Disorder

Recent news which mentions Generalized Anxiety Disorder

Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
Tickers CCC IXHL
Tags GAD Health Care Benzinga Cannabis Capital Conference
From Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Tickers CMPS MNMD NEWS
Tags Benzinga Biotech FDA
From Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Tickers IXHL NEWS
Tags Biotech Management Generalized Anxiety Disorder
From Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
Tickers MNMD NEWS
Tags Cannabis News Market News
From Benzinga
Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
Tickers MNMD
Tags Market News Cannabis FDA
From Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
Tickers MNMD
Tags Generalized Anxiety Disorder Benzinga MNMD
From Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
Tickers MNMD
Tags Psychedelics MNMD Markets
From Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
Tickers CYBN
Tags Markets Psychedelics Benzinga
From Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
Tickers FLHLF IXHL SILO
Tags fibromyalgia Psychedelics SILO
From Benzinga
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
Tickers AWKNF
Tags Ketamine Therapy Penny Stocks Global
From Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
Tickers IXHL
Tags Benzinga Generalized Anxiety Disorder Psychedelics
From Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
Tickers CYBN
Tags Cannabis DMT Entities CYBN
From Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
Tickers CYBN MNMD
Tags Management anxiety disorders Generalized Anxiety Disorder
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags Market News alcohol use disorder CYBN
From Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
Tickers MNMD
Tags News MindMed Robert Barrow
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story